Elasticity loss and tissue stiffening are signs of aging resulting from glycation. To fight against these occurrences, Silab offers Deglysome, a double effect active ingredient capable of limiting cellular and tissue damages caused by glycation and Advanced Glycation End products (AGEs). According to the company, by reducing production of AGEs and thus glycation of dermal proteins, Deglysome limits the damage caused to fibroblasts and their environment.
Rich in sulfated galactans derived from the Hypnea musciformis algae, this novel ingredient is said to support the matrix network by stimulating the formation of collagen and fibrillin networks.
More info: www.silab.fr